REVIEW ON ANALYTICAL METHOD FOR QUANTITATIVE ESTIMATION OF EFONIDIPINE HYDROCHLORIDE ETHANOLATE AND METOPROLOL SUCCINATE IN BULK AND PHARMACEUTICAL DOSAGE FORM
Dhara A. Patel* and Shuchi P. Desai
ABSTRACT
Efonidipine is a dihydropyridine calcium channel blocker, inhibits both
L-type and T-type calcium channels, Efonidipine exhibits
antihypertensive effect through vasodilatation by blocking L-type and
T-type calcium channels. Metoprolol, is a selective β1 receptor
blocker medication. It is used to treat high blood pressure, chest pain
due to poor blood flow to the heart, and a number of conditions
involving an abnormally fast heart rate. This preferential effect at
higher plasma concentrations. It works by blocking the action of
certain natural chemicals in your body, such as epinephrine, on the
heart and blood vessels. This effect lowers the heart rate, blood
pressure, and strain on the heart. This combination use for improve the
management of stage II hypertension. This review focuses on the
recent development in analytical techniques for estimation of Efonidipine Hydrochloride
Ethanolate and Metoprolol Succinate and there was no any methods have been reported for
this combination. However, for Efonidipine Hydrochloride Ethanolate HPLC, Stability RPHPLC
methods has been reported. And UV, HPLC, Stability indicating RP-HPLC, HPTLC
and UPLC methods have been reported for Metoprolol Succinate individual and along with
other.
Keywords: Analytical techniques, Efonidipine Hydrochloride Ethanolate, Metoprolol Succinate, UV, HPLC, Stability indicating RP-HPLC, HPTLC and UPLC.
[Full Text Article]